Literature DB >> 9932946

Diminished regional cerebral blood flow response to vibration in patients with blepharospasm.

R J Feiwell1, K J Black, L A McGee-Minnich, A Z Snyder, A M MacLeod, J S Perlmutter.   

Abstract

OBJECTIVE: To determine whether patients with blepharospasm have abnormal sensorimotor processing similar to patients with writer's cramp.
BACKGROUND: Blepharospasm is a focal dystonia manifest by involuntary, excessive blinking and squeezing of the eyes. Altered sensorimotor processing may contribute to the development of dystonic movements. Previously the authors demonstrated decreased vibration-induced cortical blood flow responses in hand primary sensorimotor area (PSA) in patients with hand dystonia.
METHODS: In this prospective, case-control study, seven patients with blepharospasm were compared with seven normal subjects. PET measurements of regional blood flow were obtained using bolus administration of H(2)15O at rest or during sequential vibration of either the left or the right hand or side of the mouth.
RESULTS: PSA activation decreased significantly in the patients with blepharospasm both ipsilateral (-68%; p = 0.0004) and contralateral to the side of facial stimulation (-56%; p = 0.0009). Patients had a 31% lower mean contralateral PSA response to hand vibration and a 51% smaller right supplementary motor area response to left-hand vibration than normal subjects, but these differences did not reach statistical significance.
CONCLUSIONS: Patients with blepharospasm have abnormal sensorimotor processing in response to lower face vibration. They may also have abnormal brain responses to stimulation of clinically uninvolved parts of the body, but this requires confirmation.

Entities:  

Mesh:

Year:  1999        PMID: 9932946     DOI: 10.1212/wnl.52.2.291

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

Review 2.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

Review 3.  Deep brain stimulation.

Authors:  Joel S Perlmutter; Jonathan W Mink
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

4.  Effects of botulinum toxin type A on vibration induced facilitation of motor evoked potentials in spasmodic torticollis.

Authors:  P P Urban; R Rolke
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

Review 5.  Cranial movement disorders: clinical features, pathophysiology, differential diagnosis and treatment.

Authors:  Giovanni Fabbrini; Giovanni Defazio; Carlo Colosimo; Philip D Thompson; Alfredo Berardelli
Journal:  Nat Clin Pract Neurol       Date:  2009-02

Review 6.  The role of dopamine and dopaminergic pathways in dystonia: insights from neuroimaging.

Authors:  Morvarid Karimi; Joel S Perlmutter
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-01-29

7.  A Dynamic Circuit Hypothesis for the Pathogenesis of Blepharospasm.

Authors:  David A Peterson; Terrence J Sejnowski
Journal:  Front Comput Neurosci       Date:  2017-03-07       Impact factor: 2.380

Review 8.  The Central Effects of Botulinum Toxin in Dystonia and Spasticity.

Authors:  Pavel Hok; Tomáš Veverka; Petr Hluštík; Martin Nevrlý; Petr Kaňovský
Journal:  Toxins (Basel)       Date:  2021-02-17       Impact factor: 4.546

Review 9.  Botulinum toxin physiology in focal hand and cranial dystonia.

Authors:  Barbara Illowsky Karp
Journal:  Toxins (Basel)       Date:  2012-11-20       Impact factor: 4.546

Review 10.  Research Priorities in Limb and Task-Specific Dystonias.

Authors:  Sarah Pirio Richardson; Eckart Altenmüller; Katharine Alter; Ron L Alterman; Robert Chen; Steven Frucht; Shinichi Furuya; Joseph Jankovic; H A Jinnah; Teresa J Kimberley; Codrin Lungu; Joel S Perlmutter; Cecília N Prudente; Mark Hallett
Journal:  Front Neurol       Date:  2017-05-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.